Monogenic Diabetes Misdiagnosed as Type 1
Recruiting
Observational Study
Diabetes Mellitus, Type 1
Monogenic Diabetes
Neonatal Diabetes
Maturity-onset Diabetes in the Young (MODY)
Wolfram Syndrome
Wolcott-Rallison Syndrome
Mitochondrial Diabetes
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 1 Day – 25
- Sex
- Any
- Study type
- Observational
- Participants needed
- 5,000 (estimated)
- Sponsor
- McGill University Health Centre/Research Institute of the McGill University Health Centre · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The study has two aims: 1. To (1a) determine the frequency of monogenic diabetes misdiagnosed as type 1 diabetes (T1D) and (2) to define an algorithm for case selection. 2. To discover novel genes whose mutations cause monogenic diabetes misdiagnosed as T1D.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Diagnosis of diabetes under the age of 25 as either type 1 or undetermined type.
Exclusion Criteria:
* Existing T1D autoantibody testing with a positive result
Contacts